Preclinical evidence suggests that it s time for well-designed clinical trials to test the safety and efficacy of cannabidiol in the management of acute and chronic coronary syndromes, researchers say.
moderna, pfizer and biontech have been granted emergency use authorization for this. the cdc will vote later today on whether to recommend the use of the two vaccine boosters. joining us to discuss is the chief medical officer at moderna, dr. paul burton. dr. burton, thank you for being with us. i do want to talk about something in particular because i think it s really important that we confront some concerns people may have about this booster because in particular this there are no human trials needed, they are not required for these boosters that target ba.4 and 5, before the shots can go into your arm. why not and why is that or is that not a reason for concern? good morning. look, i actually think it s a big step forward on the part of fda and regulators to consider approving a vaccine like this based on animal data alone. to really get ahead of this virus we re going to have to move quickly, but i think i can reassure people that we re
authorized based on animal data tested in mice rather than full trials with people. any concerns there? what do you say to someone who might be worried about their safety? yeah, thanks for having me, ana. when you think about vaccine safety, it s important that you have a deep belief and understanding that no corners were cut. and here when we re looking at these new boosters that are coming from both moderna and pfizer the fda took a different approach than they took with previous vaccine approvals. and what they said was these companies are making a very small change in these vaccines, they re changing slightly the strain of covid that s being covered but the rest of the vaccine is all the same. and because it s so important to have these vaccines available quickly when we are expecting to
that we ve talked about, and we have these drugs that can be used. fortunately cdc has done a lot of work to make it more available for individuals who need it, and now we re getting more data that shows that it does work. there was lots of animal data. there was some human data that shows that this works, and now we re collecting additional data. good news is that this is available and we have a lot of it. but, doctor, what should the general public be doing right now to avoid getting monkeypox. the general public, what they need to be doing is making sure if they have suspicious rash and they have a concern that they make sure their let their clinician know. otherwise they should probably be making sure that they re protecting themselves from covid these days. president biden has now tested negative for covid, he says he feels great, he s getting back to work. he will wear a mask for the next ten days. he s completed the course of paxlovid, but we know there is this phenomenon
Ojai s Community Newspaper since 1891, makers of Ojai Valley Guide magazine, local News, Ojai Real Estate Weekly, Events, Arts, Sports, Opinion and more.